Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis

Gastroenterology

Volumn 145, Issue 6, 2013, Pages

  Siddiqui, M Shadab ^a   Sterling, Richard K ^a   Luketic, Velimir A ^a   Puri, Puneet ^a   Stravitz, R Todd ^a   Bouneva, Iliana ^a   Boyett, Sherry ^a   Fuchs, Michael ^b   Sargeant, Carol ^a   Warnick, G Russell ^c   Grami, Shahrzad ^c   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Health Diagnostic Laboratory Inc   (United States)

Author keywords

Atherosclerosis; Heart Disease; NAFLD; NASH

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN B; FAT; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SMALL DENSE LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ATHEROGENESIS; BLOOD CLOTTING; BODY MASS; CARDIOVASCULAR RISK; FEMALE; HUMAN; HYPERINSULINEMIA; INFLAMMATION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIVER; MAJOR CLINICAL STUDY; MALE; METABOLISM; PARTICLE SIZE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WELLBEING;

EID: 84888240115     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.08.036     Document Type: Article

References (43)

1. J.M. Clark, F.L. Brancati, and A.M. Diehl The prevalence and etiology of elevated aminotransferase levels in the United States Am J Gastroenterol 98 2003 960 967
2. J.D. Browning, L.S. Szczepaniak, and R. Dobbins Prevalence of hepatic steatosis in an urban population in the united states: impact of ethnicity Hepatology 40 2004 1387 1395
3. C.D. Williams, J. Stengel, and M.I. Asike Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 2010 124 131
4. G. Vernon, A. Baranova, and Z.M. Younossi Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 2011 274 285
5. D. Prati, E. Taioli, and A. Zanella Updated definitions of healthy ranges for serum alanine aminotransferase levels Ann Intern Med 137 2002 1 10
6. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics-2011 update: a report from the American Heart Association Circulation 123 2010 e18 e209
7. R.S. Rosenson, J.D. Otvos, and D.S. Freedman Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial Am J Cardiol 90 2002 89 94
8. B. Lamarche, A. Tchernof, and S. Moorjani Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. prospective results from the Quebec cardiovascular study Circulation 95 1997 69 75
9. C. Herder, M. Karakas, and W. Koenig Biomarkers for the prediction of type 2 diabetes and cardiovascular disease Clin Pharmacol Ther 90 2011 52 66
10. W.C. Cromwell, J.D. Otvos, and M.J. Keyes LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study - implications for LDL management J Clin Lipid 1 2007 583 592
11. P.M. Ridker, C.H. Hennekens, and J.E. Buring C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
12. P.T. Williams, and D.E. Feldman Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore cohort Atherosclerosis 214 2010 196 202
13. S. Mora, M. Szklo, and J.D. Otvos LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the multi-ethnic study of atherosclerosis (MESA) Atherosclerosis 192 2007 211 217
14. J.D. Otvos, D. Collins, and D.S. Freedman Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial Circulation 113 2006 1556 1563
15. C. Lorenzo, A.J. Hanley, and M.J. Rewers The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the insulin resistance atherosclerosis study Diabetologia 56 2013 746 757
16. G. Assmann, H. Schulte, and A. von Eckardstein High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport Atherosclerosis 124 Suppl 1996 S11 S20
17. A.R. Sharrett, C.M. Ballantyne, and S.A. Coady Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study Circulation 104 2001 1108 1113
18. P. Simonen, A. Kotronen, and M. Hallikainen Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity J Hepatol 54 2010 153 159
19. J.P. Despres, B. Lamarche, and P. Mauriege Hyperinsulinemia as an independent risk factor for ischemic heart disease N Engl J Med 334 1996 952 957
20. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
21. S.K. Ryu, Z. Mallat, and J. Benessiano Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes [coronary heart disease] Circulation 125 2012 757 766
22. T.J. Wang, P. Gona, and M.G. Larson Multiple biomarkers for the prediction of first major cardiovascular events and death N Engl J Med 355 2006 2631 2639
23. M. Hsieh, C. Chen, and T. Lee Metabolic syndrome and homocysteine level as predictors of the severity of coronary artery disease in patients with carotid stenosis Am J Med Sci 338 2009 447 452
24. A. Kotronen, M. Peltonen, and A. Hakkarainen Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors Gastroenterology 137 2009 865 872
25. W. Dunn, R. Xu, and D.L. Wingard Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study Am J Gastroenterol 103 2008 2263 2271
26. K.E. Yun, C.Y. Shin, and Y.S. Yoon Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans Atherosclerosis 205 2009 533 537
27. W. Goessling, J.M. Massaro, and R.S. Vasan Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease Gastroenterology 135 2008 1935 1944.e1
28. S. Koba, T. Hirano, and Y. Ito Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases Atherosclerosis 189 2006 206 214
29. S.M. Grundy, J.I. Cleeman, and S.R. Daniels Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary Crit Pathw Cardiol 4 2005 198 203
30. M. Ai, S. Otokozawa, and B.F. Asztalos Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study [lipids, lipoproteins, and cardiovascular risk factors] Clin Chem 56 2010 967 976
31. K.O. Akosah, A. Schaper, and C. Cogbill Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol 41 2003 1475 1479
32. T.A. Tobey, M. Greenfield, and F. Kraemer Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man Metabolism 30 1981 165 171
33. C.J. Packard Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein Biochem Soc Trans 31 2003 1066 1069
34. C.J. Packard, T. Demant, and J.P. Stewart Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions J Lipid Res 41 2000 305 318
35. K.L. Donnelly, C.I. Smith, and S.J. Schwarzenberg Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J Clin Invest 115 2005 1343 1351
36. H. Min, A. Kapoor, and M. Fuchs Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease Cell Metabolism 15 2012 665 674
37. G. Pagano, G. Pacini, and G. Musso Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association Hepatology 35 2002 367 372
38. I. Shimomura, Y. Bashmakov, and S. Ikemoto Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes Proc Natl Acad Sci U S A 96 1999 13656 13661
39. Y. Ito, M. Fujimura, and M. Ohta Development of a homogeneous assay for measurement of small dense LDL cholesterol [lipids, lipoproteins, and cardiovascular risk factors] Clin Chem 57 2010 57 65
40. J.D. Otvos, E.J. Jeyarajah, and D.W. Bennett Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy Clin Chem 37 1991 377 386
41. J.D. Otvos, E.J. Jeyarajah, and D.W. Bennett Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement Clin Chem 38 1992 1632 1638
42. J.D. Otvos Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy Clin Lab 48 2002 171 180
43. G.R. Warnick, J.M. Benderson, and J.J. Albers Quantitation of high-density-lipoproteins subclasses after separation by dextran sulfate and Mg2 precipitation Clin Chem 28 1982 1574